DMIIR

Drugs Made In America Acquisition II Corp Right
DMIIR

47 hedge funds and large institutions have $4.53M invested in Drugs Made In America Acquisition II Corp Right in 2025 Q4 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$386K
2
+$295K
3
+$281K
4
GCL
Glazer Capital LLC
New York
+$271K
5
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$233K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
WC
26
Wealthspring Capital
New York
$57.3K
COPPSERS
27
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$56K
BNP Paribas Financial Markets
28
BNP Paribas Financial Markets
France
$48.8K
LPC
29
Lineage Point Capital
Florida
$46.2K
SAMU
30
SONA Asset Management (US)
New York
$42K
AGM
31
Alpine Global Management
New York
$42K
KPF
32
K2 Principal Fund
Ontario, Canada
$35K
MTCM
33
Mint Tower Capital Management
Netherlands
$35K
PC
34
Periscope Capital
Ontario, Canada
$35K
Verition Fund Management
35
Verition Fund Management
Connecticut
$28K
JP Morgan Chase
36
JP Morgan Chase
New York
$18.1K
DAM
37
DLD Asset Management
New York
$15.7K
CCC
38
Cable Car Capital
California
$14K
PEAK6
39
PEAK6
Illinois
$14K
QL
40
Quarry LP
New York
$11.3K
MC
41
Meteora Capital
Florida
$8.4K
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$8K
HCI
43
Harraden Circle Investments
New York
$7K
DAM
44
Deltec Asset Management
New York
$6.23K
AA
45
ABC Arbitrage
France
$5.6K
CS
46
Clear Street
New York
$3.82K
HCM
47
Highbridge Capital Management
New York
$140
1
2